Quick Answer: No published trial has tested tesamorelin plus a GLP-1 in humans Semaglutide binds GLP-1 receptors in pancreas, brain, and gut, producing glucose dependent insulin secretion, slowed gastric emptying, and central appetite suppression
In 2021, the FDA approved these medications for long-term weight management
[DOI] [PMC free article] [PubMed] [Google Scholar] 98
Genotoxicity assessments in the Ames test, gene mutation test (mouse lymphoma cells), chromosomal aberrations test (human lymphocytes) and in vivo mouse micronucleus tests were negative
At Legacy Physicians, we emphasize several optimization strategies that many prescribers overlook: Protein intake and muscle preservation: Studies show 20-30% of weight lost during rapid weight loss can come from lean muscle mass
Ozone (O), when administered intravenously in medical settings, has been shown to stimulate antioxidant defenses and enhance mitochondrial functioncritical factors in cellular energy production and immune surveillance